Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective…

Overview of attention for article published in Frontiers in Neurology, July 2024

Altmetric Badge

Mentioned by

twitter: 2 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 30,237 followers.

Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV… #FrontiersIn #Neurology https://t.co/KJ4dFAVTj

22 Jul 2024

Reply Repost Favourite

New Research: Cladribine effects on patient-reported outcomes and their clinical and biometric correlates in highly active relapsing multiple sclerosis at first switch: the observational, multicenter, prospective, phase IV… https://t.co/lVIcaxa1E4 #Frontie

18 Jul 2024

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.